Menu
Comprehensive and integrated CRDMO platform for recombinant proteins and peptide therapeutics
GMP-compliant one-stop CRDMO platform for plasmid development, commercial manufacturing, and regulatory submission
Microbial recombinant expression systems providing integrated, end-to-end CRDMO services
Our end-to-end mRNA CRDMO platform supports the project from R&D to commercial scale, fully meeting the GMP requirements.
Focusing on microbial expression systems, with comprehensive development of diverse recombinant vaccines (VLP and DNA vaccines)
High-quality circRNA custom services covering the full lifecycle of research-grade circRNA sample preparation and quality control
Yaohai Bio-Pharma delivers tailored solutions for global clients, meeting diverse project requirements with excellence and efficiency.
Proven track record of over 100 successful projects, spanning preclinical studies and Phase I/II/III clinical trials, including US–China dual submissions and Australian regulatory filings.
A robust GMP-aligned quality system with standardized SOPs, fully compliant with global regulatory guidelines across the entire product lifecycle.
Powered by industry-leading scientists and cross-functional experts, our team delivers CRDMO projects with speed, precision, and deep technical insight.
